Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.35 EUR | -0.87% | +0.13% | -18.67% |
04-30 | Bayer: strategic collaboration with Evotec | CF |
04-30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.67% | 28.73B | |
+32.90% | 704B | |
+28.53% | 577B | |
-4.39% | 348B | |
+18.16% | 327B | |
+4.56% | 288B | |
+14.83% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.55% | 147B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer : Seeks Approval For Cancer Treatment Combinations In US, EU